Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
NCT ID: NCT01784822
Last Updated: 2017-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2013-02-28
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients
NCT01794338
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
NCT02228889
Comparative Study of Biologic Mesh Versus Repair With Component Separation.
NCT01295125
Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh
NCT02041494
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
NCT04779918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Zenapro™ Hybrid Hernia Repair Device
Device to be used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
Zenapro™ Hybrid Hernia Repair Device
Device will be placed during open or laparoscopic hernia repair.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zenapro™ Hybrid Hernia Repair Device
Device will be placed during open or laparoscopic hernia repair.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need for abdominal wall repair with reinforcement or bridging material to obtain the desired surgical result
Exclusion Criteria
* Device intended to be used in an infected wound
* Known sensitivity to porcine material
* Pregnant or planning pregnancy in the future
* Life expectancy of less than 12 months from the date of the index procedure
* Hernia too large to be covered with a single device with at least 4-5 cm of tissue overlap on all sides
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University
Durham, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
University of Tennessee
Knoxville, Tennessee, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.